Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | February 1, 2007 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00458913 |
| Study Type: | Interventional |
| Intervention: | Drug: bortezomib|Drug: cisplatin |
| Study Design: | Allocation: Non-Randomized|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | European Organization for Research and Treatment of Cancer |
| Ages: | Adult|Senior |
| Enrollment: | 76 |
| Funded By: | Other |
| First Received: | April 9, 2007 |
| End Date: | |
| Last Updated: | June 11, 2010 |
| Last Verified: | June 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
